Anixa Biosciences Inc Quarterly Return On Assets in % from Q1 2012 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Anixa Biosciences Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q4 2024.
  • Anixa Biosciences Inc Return On Assets for the quarter ending January 31, 2025 was -56.9 %, a 39.1% decline year-over-year.
  • Anixa Biosciences Inc annual Return On Assets for 2024 was -53.3 %, a 46.7% decline from 2023.
  • Anixa Biosciences Inc annual Return On Assets for 2023 was -36.3 %, a 12.5% increase from 2022.
  • Anixa Biosciences Inc annual Return On Assets for 2022 was -41.5 %, a 1.27% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -56.9 -16 -39.1% Nov 1, 2024 Jan 31, 2025
Q3 2024 -53.3 -17 -46.7% Aug 1, 2024 Oct 31, 2024
Q2 2024 -50.4 -12.8 -34.2% May 1, 2024 Jul 31, 2024
Q1 2024 -45.6 -9.1 -25% Feb 1, 2024 Apr 30, 2024
Q4 2023 -40.9 -1.93 -4.95% Nov 1, 2023 Jan 31, 2024
Q3 2023 -36.3 +5.17 +12.5% Aug 1, 2023 Oct 31, 2023
Q2 2023 -37.6 +3.76 +9.1% May 1, 2023 Jul 31, 2023
Q1 2023 -36.5 +8.04 +18.1% Feb 1, 2023 Apr 30, 2023
Q4 2022 -39 +0.68 +1.72% Nov 1, 2022 Jan 31, 2023
Q3 2022 -41.5 -0.52 -1.27% Aug 1, 2022 Oct 31, 2022
Q2 2022 -41.3 +3.53 +7.87% May 1, 2022 Jul 31, 2022
Q1 2022 -44.5 +7.76 +14.9% Feb 1, 2022 Apr 30, 2022
Q4 2021 -39.7 +58.3 +59.5% Nov 1, 2021 Jan 31, 2022
Q3 2021 -41 +76.2 +65% Aug 1, 2021 Oct 31, 2021
Q2 2021 -44.8 May 1, 2021 Jul 31, 2021
Q1 2021 -52.2 Feb 1, 2021 Apr 30, 2021
Q4 2020 -97.9 Nov 1, 2020 Jan 31, 2021
Q3 2020 -117 Aug 1, 2020 Oct 31, 2020
Q3 2018 -196 -126 -180% Aug 1, 2018 Oct 31, 2018
Q2 2018 -109 -11 -11.2% May 1, 2018 Jul 31, 2018
Q1 2018 -59.7 +35.8 +37.5% Feb 1, 2018 Apr 30, 2018
Q4 2017 -40.7 +79.5 +66.2% Nov 1, 2017 Jan 31, 2018
Q3 2017 -69.8 +2.35 +3.26% Aug 1, 2017 Oct 31, 2017
Q2 2017 -98.5 -31.7 -47.4% May 1, 2017 Jul 31, 2017
Q1 2017 -95.5 -30.5 -47% Feb 1, 2017 Apr 30, 2017
Q4 2016 -120 -51.9 -76% Nov 1, 2016 Jan 31, 2017
Q3 2016 -72.2 -59.6 -476% Aug 1, 2016 Oct 31, 2016
Q2 2016 -66.8 -37.2 -125% May 1, 2016 Jul 31, 2016
Q1 2016 -65 -54.5 -520% Feb 1, 2016 Apr 30, 2016
Q4 2015 -68.3 -48.9 -252% Nov 1, 2015 Jan 31, 2016
Q3 2015 -12.5 +76.3 +85.9% Aug 1, 2015 Oct 31, 2015
Q2 2015 -29.6 +65 +68.7% May 1, 2015 Jul 31, 2015
Q1 2015 -10.5 +146 +93.3% Feb 1, 2015 Apr 30, 2015
Q4 2014 -19.4 +144 +88.1% Nov 1, 2014 Jan 31, 2015
Q3 2014 -88.8 +68.6 +43.6% Aug 1, 2014 Oct 31, 2014
Q2 2014 -94.6 +44.9 +32.2% May 1, 2014 Jul 31, 2014
Q1 2014 -157 -49.9 -46.6% Feb 1, 2014 Apr 30, 2014
Q4 2013 -163 -78.7 -93.2% Nov 1, 2013 Jan 31, 2014
Q3 2013 -157 -92.9 -144% Aug 1, 2013 Oct 31, 2013
Q2 2013 -140 -68.9 -97.5% May 1, 2013 Jul 31, 2013
Q1 2013 -107 -31.6 -42% Feb 1, 2013 Apr 30, 2013
Q4 2012 -84.5 Nov 1, 2012 Jan 31, 2013
Q3 2012 -64.5 Aug 1, 2012 Oct 31, 2012
Q2 2012 -70.6 May 1, 2012 Jul 31, 2012
Q1 2012 -75.3 Feb 1, 2012 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.